Labcorp Holdings INC 8-K filings

Labcorp's Board of Directors has declared a cash dividend of $0.72 per share of common stock, payable on June 11, 2025, to stockholders of record as of May 29, 2025.

Labcorp Holdings Inc. will release its first quarter 2025 financial results before the market opens on April 29, 2025, and will host a conference call and webcast to discuss the results.

Labcorp announced strong fourth-quarter and full-year 2024 results, exceeding prior year performance and providing a positive outlook for 2025.

Labcorp Holdings Inc. amended its receivables purchase agreement, increasing the facility limit from $300 million to $700 million and adding new purchasers.

Labcorp's executive management team will participate in a fireside chat at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025.

Labcorp has declared a cash dividend of $0.72 per share, payable on March 12, 2025, to shareholders of record as of February 27, 2025.

Labcorp will release its fourth quarter 2024 financial results before the market opens on February 6, 2025, and will host a conference call to discuss the results.

Labcorp has announced the retirement of CFO Glenn Eisenberg and the appointment of Julia Wang as his successor, effective December 2, 2024.

Labcorp reported a revenue increase to $3.28 billion and adjusted EPS of $3.50 for the third quarter of 2024, while also updating its full-year guidance.

Labcorp's Board of Directors has declared a cash dividend of $0.72 per share, payable on December 13, 2024, to shareholders of record on November 26, 2024.

Labcorp will announce its third quarter 2024 financial results before the market opens on October 24, 2024, followed by a conference call and webcast.

Labcorp has successfully issued $2 billion in senior notes to refinance existing debt and for general corporate purposes.

Labcorp has announced the pricing of a $2 billion senior notes offering through its subsidiary, Laboratory Corporation of America Holdings, to refinance existing debt and for general corporate purposes.

Labcorp's executive management team will present at the Baird 2024 Global Healthcare Conference on September 10th.

Labcorp has entered into a three-year $300 million accounts receivable securitization facility with PNC Bank, which includes an option to increase the facility to $700 million.

Labcorp reported a 6.2% increase in revenue and a significant rise in diluted EPS for the second quarter of 2024, alongside an updated full-year guidance.

Labcorp's Board of Directors has declared a cash dividend of $0.72 per share, payable on September 13, 2024, to shareholders of record on August 29, 2024.

Labcorp will release its second quarter 2024 financial results before the market opens on August 1, 2024, followed by a conference call and webcast to discuss the results.

Labcorp presented its growth strategy at the William Blair Growth Stock Conference, emphasizing its market leadership, expansion plans, and the acquisition of select Invitae assets.

Labcorp's executive management team will participate in a presentation at the 44th Annual William Blair Growth Stock Conference on June 4th.

Labcorp has completed its holding company reorganization, with Labcorp Holdings Inc. becoming the successor issuer and its shares now trading on the NYSE under the ticker symbol LH.

Labcorp held its 2024 Annual Meeting of Shareholders, electing directors, approving executive compensation, and ratifying the appointment of Deloitte & Touche LLP as its independent auditor.

Labcorp will webcast its Annual Meeting of Shareholders live on May 14th, providing online access for investors.

Labcorp reported a 4.6% increase in revenue and raised its full-year adjusted EPS guidance, driven by strong base business growth and strategic acquisitions.

Labcorp's Board of Directors has declared a cash dividend of $0.72 per share, payable on June 12, 2024, to shareholders of record as of May 28, 2024.

Labcorp will announce its first quarter 2024 financial results before market open on April 25, 2024, followed by a conference call and webcast.

Labcorp announced its fourth quarter and full year 2023 results, showing revenue growth but a net loss for the quarter, and provided its 2024 financial guidance.

Labcorp will release its fourth quarter and full year 2023 financial results before the market opens on February 15, 2024, followed by a conference call and webcast to discuss the results.

Labcorp's Board of Directors has declared a cash dividend of $0.72 per share, payable on March 13, 2024, to shareholders of record as of February 27, 2024.